ReviewClinical, cosmetic and investigational dermatology2026
Global Mapping and Trends in Scabies Research Over Four Decades: A Bibliometric Analysis Supporting the WHO Elimination Agenda.
Review in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Scabies is a neglected tropical disease with at least 200 million people affected worldwide at any one time and a disproportionate burden in resource-limited settings. Although World Health Organization (WHO) prioritization has increased attention to scabies control, the evolution, geographic distribution, collaboration patterns, and policy alignment of the global research landscape remain incompletely characterized. This study mapped publication trends, research inequities, and thematic shifts in relation to the WHO control agenda. Methods: A bibliometric analysis was conducted using Scopus and Web of Science records published from 1 January 1980 through 31 December 2025. Records were harmonized, screened, and deduplicated using R-bibliometrix version 5.1.1 and visualized using Biblioshiny version 5.1.1. Results: After cross-database screening and deduplication, 3696 publications were included. The annual growth rate was 3.24%, international collaboration was 13.84%, and mean citations were 13.98 per document. Australia (1170 publications), the United States (945), China (502), and the United Kingdom (455) were the leading contributors. Thematic patterns shifted from classical topical scabicides toward oral ivermectin, mass drug administration (MDA), standardized diagnosis, and implementation-oriented research, while resistance and crusted scabies emerged as prominent recent themes. Conclusion: Publication growth accelerated after 2017, temporally coinciding with WHO recognition of scabies as a neglected tropical disease; however, the descriptive design does not establish causality. Research output remains geographically concentrated, with no African or Latin American country represented among the 10 most productive countries. Broader international collaboration, research-capacity strengthening in highly endemic settings, and operational research on diagnosis, MDA, surveillance, and treatment effectiveness are priorities for the 2030 control agenda.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.